Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	388.49	394	622.91	282.17	71.93	16.69
Short-Term Investments	-	13.04	2.81	2.48	1.84	-
Cash & Short-Term Investments	388.49	407.03	625.72	284.65	73.77	16.69
Cash Growth	-36.17%	-34.95%	119.82%	285.85%	342.01%	-58.28%
Accounts Receivable	1,092	1,108	557.05	522.82	275.59	767.59
Other Receivables	-	18.66	12.95	10.73	18.48	6.05
Receivables	1,101	1,158	589.01	550.02	311.84	774.12
Inventory	781.32	784.81	821.68	1,050	987.04	136.18
Prepaid Expenses	-	22.14	20.17	37.77	31.22	7.19
Other Current Assets	112.57	55.99	45.14	12.44	6.16	3.53
Total Current Assets	2,384	2,428	2,102	1,935	1,410	937.71
Property, Plant & Equipment	477.52	363.11	170.87	190.16	60.27	11.67
Long-Term Investments	-	-	-	-	44.7	34.16
Goodwill	310.74	267.45	261	252.24	233.02	12.79
Other Long-Term Assets	52.8	45.21	49.84	19.19	16.69	0.46
Total Assets	3,225	3,103	2,583	2,397	1,765	996.8
Accounts Payable	195.47	161.78	290.38	345.19	491.15	220.58
Accrued Expenses	-	46.02	46.1	28.02	32.6	28.88
Short-Term Debt	333.33	303.8	176.61	107.51	36.38	36.59
Current Income Taxes Payable	-	33.67	28.83	50.57	72.52	60.12
Current Unearned Revenue	-	-	-	-	-	0.63
Other Current Liabilities	73.65	0.05	0.05	0.05	0.03	0.13
Total Current Liabilities	602.45	545.32	541.98	531.33	632.68	346.93
Long-Term Debt	213.6	212.45	-	8.7	-	-
Long-Term Leases	18.3	18.01	17.43	16.86	-	-
Long-Term Deferred Tax Liabilities	8.67	9	9.95	11.01	0.39	0.07
Other Long-Term Liabilities	1.29	1.29	0.43	-	-	-
Total Liabilities	844.3	786.06	569.79	567.89	633.06	347
Common Stock	110.42	110.42	108.98	101.81	100	100
Additional Paid-In Capital	-	565.8	508.44	192.46	112.53	112.53
Retained Earnings	-	1,641	1,358	1,432	919.11	437.27
Comprehensive Income & Other	2,270	-	37.73	102.97	-	-
Shareholders' Equity	2,380	2,317	2,014	1,829	1,132	649.8
Total Liabilities & Equity	3,225	3,103	2,583	2,397	1,765	996.8
Total Debt	565.23	534.25	194.04	133.07	36.38	36.59
Net Cash (Debt)	-176.74	-127.22	431.68	151.58	37.39	-19.9
Net Cash Growth	-	-	184.78%	305.40%	-	-
Net Cash Per Share	-3.19	-2.30	8.39	2.99	0.75	-0.40
Filing Date Shares Outstanding	52.25	55.21	50.91	50.91	50	50
Total Common Shares Outstanding	52.25	55.21	50.91	50.91	50	50
Working Capital	1,781	1,882	1,560	1,404	777.36	590.78
Book Value Per Share	45.56	41.98	39.56	35.92	22.63	13.00
Tangible Book Value	2,070	2,050	1,753	1,577	898.62	637.01
Tangible Book Value Per Share	39.61	37.13	34.43	30.97	17.97	12.74

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.